This approach aimed to elucidate the fundamental mechanisms of CD8+ T cells in tumor progression, develop new molecular stratification and prognostic features, and assist in determining the benefits of different treatment modalities for patients to achieve maximum clinical benefit. The gene discussed is CD8A; the disease is neoplasm.